Gene · 5566
Papers2,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictive Analysis of Yi-Gai-San's Multifaceted Mechanisms for Tremor-dominant Parkinson's Disease via Network Pharmacology and Molecular Docking Validation. | Curr Med Chem | 2024 | 38879763 | PubTator, text mining | PubMed |
| PRKACA/PRKACB Fusions in Pancreatobiliary Intraductal Oncocytic Papillary Neoplasms Including Those With Atypical Morphology: An Analysis of 22 Cases Expanding Morphologic Spectrum. | Am J Surg Pathol | 2024 | 38841868 | PubTator, text mining | PubMed |
| Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification. | Molecules | 2024 | 38675723 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Lactotroph Pituitary Neuroendocrine Tumors via RNA Sequencing and Ingenuity Pathway Analysis. | Neuroendocrinology | 2024 | 38643763 | PubTator, text mining | PubMed |
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion. | Front Oncol | 2024 | 38606105 | PubTator, text mining | PubMed |
| Ex vivo liver resection and auto-transplantation and special systemic therapy in perihilar cholangiocarcinoma treatment. | World J Gastrointest Surg | 2024 | 38577079 | PubTator, text mining | PubMed |
| Accurate network pharmacology and novel ingredients formula of herbal targeting estrogen signaling for psoriasis intervention. | J Ethnopharmacol | 2024 | 38554853 | PubTator, text mining | PubMed |
| DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma. | PLoS Genet | 2024 | 38512964 | PubTator, text mining | PubMed |
| DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. | Cell Rep Med | 2024 | 38508137 | PubTator, text mining | PubMed |
| Frequent protein kinase A regulatory subunit A1 mutations but no GNAS mutations as potential driver in sporadic cardiac myxomas. | Cardiovasc Pathol | 2024 | 38492686 | PubTator, text mining | PubMed |
| Timosaponin A3 Induces Anti-Obesity and Anti-Diabetic Effects In Vitro and In Vivo. | Int J Mol Sci | 2024 | 38474161 | PubTator, text mining | PubMed |
| The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association. | J Virol | 2024 | 38445884 | PubTator, text mining | PubMed |
| Neoplastic Progression in Macroscopic Precursor Lesions of the Pancreas. | Arch Pathol Lab Med | 2024 | 38386006 | PubTator, text mining | PubMed |
| Discovery of a Cushing's syndrome protein kinase A mutant that biases signaling through type I AKAPs. | Sci Adv | 2024 | 38381834 | PubTator, text mining | PubMed |
| PRKACA-related, atrial defects-polydactyly-multiple congenital malformation syndrome in an Indian patient. | Am J Med Genet A | 2024 | 38357848 | PubTator, text mining | PubMed |
| ASIC1 promotes migration and invasion of hepatocellular carcinoma via the PRKACA/AP-1 signaling pathway. | Carcinogenesis | 2024 | 38306794 | PubTator, text mining | PubMed |
| Mechanism of pachymic acid in the treatment of gastric cancer based on network pharmacology and experimental verification. | World J Gastrointest Oncol | 2024 | 38292852 | PubTator, text mining | PubMed |
| Substance basis and pharmacological mechanism of heat-clearing herbs in the treatment of ischaemic encephalopathy: a systematic review and network pharmacology. | Ann Med | 2024 | 38285889 | PubTator, text mining | PubMed |
| TRPM8 inhibits substance P release from primary sensory neurons via PKA/GSK-3beta to protect colonic epithelium in colitis. | Cell Death Dis | 2024 | 38280896 | PubTator, text mining | PubMed |
| Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-Trans-Retinoic Acid-Induced Neuronal Differentiation. | Int J Mol Sci | 2024 | 38256121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5566/papers?page=8